Anti-interleukin-6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis
European Journal of Immunology Sep 01, 2017
Fleischer S, et al. – Study's aspiration was to delineate novel cytokine–mediated B cell functions in rheumatoid arthritis (RA). Outcomes of this work outlined hitherto unknown abnormal B cell functions in RA patients. These functions exhibited a relation to the unbalanced cytokine network and were potentially relevant for RA pathogenesis and treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
